Petros Pharmaceuticals, Inc. financial data

Symbol
PTPI on Nasdaq
Industry
Pharmaceutical Preparations
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 192 % -5.45%
Quick Ratio 17.7 % -35.3%
Debt-to-equity 241 % +149%
Return On Equity -76.6 % +42.7%
Return On Assets -22 % +67.6%
Operating Margin -173 % -70.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7M shares +231%
Common Stock, Shares, Outstanding 9.3M shares +339%
Entity Public Float 3.15M USD -75%
Common Stock, Value, Issued 930 USD +341%
Weighted Average Number of Shares Outstanding, Basic 7.39M shares +249%
Weighted Average Number of Shares Outstanding, Diluted 7.39M shares +249%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.42M USD -28.7%
Research and Development Expense 3.15M USD +50%
Operating Income (Loss) -16.1M USD +25.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.06M USD +74%
Income Tax Expense (Benefit) 10.5K USD +348%
Net Income (Loss) Attributable to Parent -7.06M USD +67.9%
Earnings Per Share, Basic -6.55 USD/shares +38.1%
Earnings Per Share, Diluted -6.55 USD/shares +38.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.5M USD +1.35%
Accounts Receivable, after Allowance for Credit Loss, Current 1.78M USD -31.1%
Inventory, Net 1.43M USD -34.3%
Other Assets, Current 86.5K USD +173%
Assets, Current 14M USD +6.3%
Property, Plant and Equipment, Net 23.8K USD -30%
Operating Lease, Right-of-Use Asset 154K USD -47.8%
Intangible Assets, Net (Excluding Goodwill) 7.54M USD -28.8%
Other Assets, Noncurrent 294K USD
Assets 25.2M USD -12.4%
Accounts Payable, Current 791K USD -55.7%
Accrued Liabilities, Current 6.67M USD +39.7%
Liabilities, Current 9.98M USD +25.2%
Operating Lease, Liability, Noncurrent 138K USD -47.6%
Other Liabilities, Noncurrent 108K USD -41.2%
Liabilities 16M USD +1.27%
Retained Earnings (Accumulated Deficit) -102M USD -7.45%
Stockholders' Equity Attributable to Parent 8.07M USD -37.7%
Liabilities and Equity 25.2M USD -12.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.13M USD -51.6%
Net Cash Provided by (Used in) Financing Activities -1.12M USD -213%
Common Stock, Shares Authorized 250M shares +66.7%
Common Stock, Shares, Issued 9.3M shares +339%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.26M USD -104%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.46M USD +1.02%
Interest Paid, Excluding Capitalized Interest, Operating Activities 142K USD
Deferred Tax Assets, Valuation Allowance 18.1M USD +5.86%
Operating Lease, Liability 263K USD -35.1%
Lessee, Operating Lease, Liability, to be Paid 319K USD -37.3%
Operating Lease, Liability, Current 125K USD -12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 81.1K USD -47.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 155K USD -18%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD -45.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 82.3K USD +1.5%
Deferred Tax Assets, Operating Loss Carryforwards 9.48M USD +57.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 82.3K USD +1.5%
Operating Lease, Payments 189K USD +0.87%
Additional Paid in Capital 110M USD +2.03%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 700K USD -12.5%
Depreciation, Depletion and Amortization 3.07M USD -25.8%
Share-based Payment Arrangement, Expense 16.8K USD -61.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%